The India polymerase chain reaction (PCR) devices market size reached USD 0.85 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1.04 Million by 2033, exhibiting a growth rate (CAGR) of 2.32% during 2025-2033. The market is fueled by pharmaceutical and biotechnology growth, stricter quality control regulations, and rising environmental testing demands. Increased food safety standards, government support for domestic manufacturing, and technological advancements in portable and automated instruments are accelerating adoption. Expanding research and development (R&D) investments and pollution monitoring needs are further expanding the India polymerase chain reaction (PCR) devices market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 0.85 Million |
Market Forecast in 2033 | USD 1.04 Million |
Market Growth Rate 2025-2033 | 2.32% |
Increasing Demand for Point-of-Care PCR Devices in India
The growing demand for point-of-care (POC) PCR systems due to their rapid diagnostic capabilities and portability is driving the India polymerase chain reaction (PCR) devices market growth. These devices enable real-time testing in decentralized settings, such as clinics, pharmacies, and remote healthcare centers, reducing dependency on centralized labs. The COVID-19 pandemic further accelerated this trend, as POC PCR devices were crucial for quick and accurate detection of infections. Additionally, rising awareness regarding early disease diagnosis and implementation of government initiatives to strengthen healthcare infrastructure are driving adoption. The Indian government has strengthened its healthcare infrastructure under the National Health Mission (NHM), leading to the establishment of 167,275 Sub Centres (SCs), 26,636 Primary Health Centres (PHCs), and 6,155 Community Health Centres (CHCs) as of June 2024. With the growth in the First Referral Unit (FRUs) from 940 in 2005 to 3,108 in 2024, the growing demand for diagnostic services underscores the rising demand for diagnostic services, which in turn necessitates the availability of PCR devices in rural healthcare environments. Apart from this, companies are focusing on developing compact, cost-effective, and user-friendly PCR systems to cater to India’s diverse healthcare needs. With increasing applications in infectious diseases, oncology, and genetic testing, POC PCR devices are expected to gain significant traction, especially in tier-2 and tier-3 cities where lab access is limited.
Expansion of Multiplex PCR Technology in Diagnostics and Research
Multiplex PCR technology is gaining prominence in India’s PCR devices market due to its ability to detect multiple pathogens in a single test, thereby improving efficiency and reducing costs. This technology is particularly valuable in infectious disease testing, oncology, and food safety diagnostics. The growing burden of infectious diseases, such as tuberculosis, dengue, and COVID-19, has increased the need for high-throughput diagnostic solutions. A research report from the IMARC Group indicates that the market for diagnostic laboratories in India is expected to grow at a compound annual growth rate (CAGR) of 11.21% from 2025 to 2033. In addition, research institutes and diagnostic labs are increasingly adopting multiplex PCR for its accuracy and time-saving benefits. Furthermore, continual advancements in automation and bioinformatics are enhancing the performance of multiplex PCR systems. Therefore, this is creating a positive India polymerase chain reaction (PCR) devices market outlook. As India’s healthcare sector emphasizes precision medicine and advanced diagnostics, the demand for multiplex PCR devices is expected to rise, supported by investments from both the public and private sectors.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on type and end user.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes quantitative PCR and digital PCR.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered | Quantitative PCR, Digital PCR |
End Users Covered | Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Others |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |